You asked:
Holistic Needs Assessments (HNAs)
1) Do patients with secondary breast cancer have a Holistic Needs Assessment (HNA), used to plan their care, conducted at the point of diagnosis (of their secondary breast cancer) and/or as their treatment changes?
2) If yes, do the HNAs cover the following areas?
Access to a Clinical Nurse Specialist
3) How many people with secondary breast cancer are currently under the care of your Trust?
4) Do all patients with secondary breast cancer under the care of your Trust have access to a Clinical Nurse Specialist (CNS) with the appropriate skills, knowledge and experience of secondary breast cancer? (yes/no)
5) If yes, do these nurses:
a) Provide care to secondary breast cancer patients only? (yes/no)
b) Provide care to both primary and secondary breast cancer patients? (yes/no)
6) If yes, please provide the number of CNS posts that fall under each of these categories (as applicable):
a) CNSs that provide care to secondary breast cancer patients only
b) CNSs that provide care to both primary and secondary breast cancer patients
7) If there are CNS posts within your Trust that provide care to both primary and secondary breast cancer patients, please tell us if they:
a) Work in a combined role (where the care of both primary and secondary breast cancer patients is part of their formal job description) (yes/no)
b) Work across both areas but their formal job description only covers primary breast cancer patients (yes/no)
Information and referrals
8) At diagnosis and/or during the time they are under the care of your Trust, are patients with secondary breast cancer provided with the following information and/or referred to the following services?
Treatment Summaries
9) Do patients with secondary breast cancer receive a Treatment Summary* at the end of each significant phase of treatment? (yes/no)
Access to Health and Wellbeing Events
10) Does your Trust offer a Health and Wellbeing event* suitable for patients with secondary breast cancer? (yes/no)

Download response Support for secondary breast cancer patients. 041018